Publication | Closed Access

Sorafenib Versus Observation Following Radical Metastasectomy for Clear-cell Renal Cell Carcinoma: Results from the Phase 2 Randomized Open-label RESORT Study

UrologySurgical OncologyGenitourinary CancerMedicineSurgeryCancer TreatmentPhase 2Oncology